[Federal Register Volume 68, Number 24 (Wednesday, February 5, 2003)]
[Notices]
[Page 5887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-2782]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-03-40]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Anne O'Connor , CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: Examining the Effectiveness of HIV Prevention 
Messages--New--National Center for HIV, STD, and TB Prevention 
(NCHSTP), Centers for Disease Control and Prevention (CDC). This 
project involves the development and cognitive testing of HIV 
prevention messages in the format of computerized brochures. The 
efficacy of various types of prevention messages will be evaluated in 
three experimental studies with populations at risk of acquiring or 
transmitting HIV. The studies will test different ways of 
communicating, framing and presenting HIV prevention messages. Outcomes 
to be examined include the extent to which the message is considered 
acceptable, comprehensible, and credible by the intended audience, as 
well as the extent to which the message influences knowledge, 
attitudes, and readiness or intentions to reduce or eliminate risk 
behaviors. Data will be collected using audio-computer assisted self-
interviews. The results will be used by CDC, and other organizations 
and researchers to inform prevention activities. There is no cost to 
the respondents.

----------------------------------------------------------------------------------------------------------------
                                                                      No. of      Average burden
                      Form                            No. of       responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Eligibility Screener............................            1600               1           15/60             400
Message Complexity Study Questionnaire..........             200               1               1             200
Message Framing Study Questionnaire.............             600               1               1             600
Message Presentation Study Questionnaire........             450               1               1             450
      Total.....................................  ..............  ..............  ..............            1650
----------------------------------------------------------------------------------------------------------------


    Dated: January 30, 2003.
Thomas Bartenfeld,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 03-2782 Filed 2-4-03; 8:45 am]
BILLING CODE 4163-18-P